ASX rose on soft inflation and rate cut hopes, real estate stocks rallied and DroneShield soared on record revenue.

The ASX found some momentum in the energy sector today, rising 0.08pc despite general anxieties over US tariff impacts.

Everest Metals’ gold projects promise near-term cashflow while its Mt Edon rubidium project has the potential to be truly ...

How an under-the-radar Aussie player is wiring up Asia’s smart cities, feeding AI with live data from half a million devices.

With the Sydney Marathon looming, this tech editor turns to Samsung’s AI running coach. Can this smart watch salvage a ...

A desktop review and first-pass fieldwork identifies several iron-enriched rock chip samples at CuFe’s Camp Creek project in ...

Over a working life, a series of seemingly small choices can cost women up to $1m in lost earnings and wealth.

Opthea investors are fighting over a smaller pool of cash after the failed eye drug developer reported $80 million of June quarter outflows.

The ASX lifted 0.11pc in the first hour this morning, gaining on a rising oil price and resulting strength in the energy sector.

Island Pharmaceuticals hopes the US FDA will approve its acquired asset Galidesivir on the back of animal testing alone.

Phase 2 drilling by Ora Banda at the Davyhurst project expands the multi-lode gold system at Little Gem to a strike of more than 1km.

Dimerix, Audeara, LTR Pharma and EZZ Life Science are among ASX health companies reporting quarterly results this week.